Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. META Study Group. 1998

C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
Emergency Medicine and Toxicology, Carolinas Medical Center, Charlotte, North Carolina 28232-2861, USA.

OBJECTIVE Toxic manifestations following ethylene glycol exposure are due to accumulation of metabolites, particularly glycolate. We characterized glycolate elimination kinetics and dialysis properties in a series of ethylene glycol poisonings. METHODS Patients who ingested ethylene glycol and received fomepizole (4-methylpyrazole; 4-MP) +/- hemodialysis were prospectively evaluated. Serial blood samples for ethylene glycol, glycolate, pH, and bicarbonate were drawn to determine glycolate elimination rate, t1/2, and correlations between initial glycolate and initial markers of acidosis. Dialyzer inlet and outlet samples were obtained to measure hemodialysis glycolate clearance. Plasma ethylene glycol and glycolate were determined by gas chromatography. RESULTS Ten patients, mean age 49 years (range 28-73 years), presented a mean of 10.5 hours (range 3.5-21.5 hours) after ethylene glycol ingestion. Mean initial ethylene glycol was 18.5 mmol/L (range 0.8-62.2 mmol/L) (115 mg/dL; range 5-386 mg/dL) and glycolate was 17.0 mmol/L (range 10.0-23.7 mmol/L). Nine of 10 underwent hemodialysis. Nonhemodialysis (n = 4) elimination rate was 1.08 +/- 0.67 mmol/L/h (mean +/- SD) and t1/2 was 626 +/- 474 minutes. Elimination t1/2 during hemodialysis (n = 8) was 155 +/- 42 minutes. Hemodialysis clearance (n = 5) was 170 +/- 23 mL/min with flow rates 250-400 mL/min. Pearson correlation coefficients were: anion gap vs glycolate r2 = 0.65 (p = 0.005), bicarbonate vs glycolate r2 = 0.10 (NS) and pH vs glycolate r2 = 0.06 (NS). CONCLUSIONS Glycolate has a slow elimination rate and long half-life. Hemodialysis effectively clears glycolate. An increased anion gap correlates with the presence of glycolate. Hemodialysis is projected as useful for ethylene glycol-poisoned patients with anion gap acidosis and low ethylene glycol blood levels.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011041 Poisoning A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. Poisonings
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D005260 Female Females
D006016 Glycolates Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon. 2-Hydroxyacetates,Glycolate Ethers,Hydroxyacetate Ethers,Hydroxyacetates,Hydroxyacetic Acids,2 Hydroxyacetates,Acids, Hydroxyacetic,Ethers, Glycolate,Ethers, Hydroxyacetate
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
January 1984, Acta medica Scandinavica,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
April 1989, Veterinary and human toxicology,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
June 1990, Arhiv za higijenu rada i toksikologiju,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
January 1996, Journal of toxicology. Clinical toxicology,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
January 1987, Journal of toxicology. Clinical toxicology,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
August 1981, The New England journal of medicine,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
January 1983, Wiadomosci lekarskie (Warsaw, Poland : 1960),
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
October 1986, The Journal of pediatrics,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
January 1986, The Journal of pediatrics,
C L Moreau, and W Kerns, and C A Tomaszewski, and K E McMartin, and S R Rose, and M D Ford, and J Brent
April 2009, Journal of analytical toxicology,
Copied contents to your clipboard!